Responsibility 01.20.2022
Volunteers from Amgen’s sales fleet are helping the company reach its sustainability goals.
Science & Innovation 01.14.2021
Patients 01.12.2022
Press Releases 12.20.2021
Otezla is now the first and only oral treatment approved for adult patients across all severities of plaque psoriasis.
Press Releases 12.17.2021
COVID-19
Check here for Amgen updates, Amgen product information, public health resources, and other pertinent information related to COVID-19.
PRESS RELEASE
Amgen is a pioneer in the science of using living cells to make biologic medicines.
Amgen’s medicines treat serious illnesses and typically address diseases with a limited number of treatment options.
Making a positive difference in the world is at the heart of what we do at Amgen—and it goes beyond making vital medicines.
Amgen is a pioneer in the science of using living cells to making biologic medicines, leading and guiding the biotech industry.
Encounter opportunities both new and undiscovered, as we embrace leading-edge technologies, invest in our talents, and maximize our potential.
